Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | See remarks below. | September 04, 2026 | September 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date September 04, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,231 |
Reported balance
After 2026-09-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-04 · Sale · Disposed 3,000 · Balance 65,231 F1: Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 9, 2026 20:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 3,000 | $98.35 | $295,050.00 |
DisclosureSEC source: 0001346672-26-000010 · form4-09092026_080951.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,231 F1 · balance_after: Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · derivative · entry 6 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,094 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 4,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · derivative · entry 5 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,692 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 843 | $92.54 | $78,011.22 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · nonDerivative · entry 4 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,760 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · nonDerivative · entry 3 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 1,889 | $92.54 | $174,808.06 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,509 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,626 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000006 · form4-02272026_090238.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,249 Underlying: Common Stock · 2,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F2 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 1,057 | $99.51 | $105,182.07 |
DisclosureSEC source: 0001346672-26-000006 · form4-02272026_090238.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,706 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000006 · form4-02272026_090238.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 9,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000004 · form4-02252026_020224.xml · derivative · entry 4 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,818 Underlying: Common Stock · 9,818 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F4 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000004 · form4-02252026_020224.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,246 Underlying: Common Stock · 2,246 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 942 | $98.62 | $92,900.04 |
DisclosureSEC source: 0001346672-26-000004 · form4-02252026_020224.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,137 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000004 · form4-02252026_020224.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 795 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment from May 1, 2025 through February 20, 2026. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 22:33 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 4,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000002 · form4-02232026_100203.xml · derivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Chief Legal · Corporate Affairs & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,692 Underlying: Common Stock · 4,692 shares Expires 2026-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 4,692 RSUs, which will vest on March 6, 2026. F2 · derivative.underlying_shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 4,692 RSUs, which will vest on March 6, 2026. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:53 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004989 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,094 Underlying: Common Stock · 2,094 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 2,094 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026. F3 · derivative.expiration_date: 2,094 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:53 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 824 | $104.86 | $86,404.64 |
DisclosureSEC source: 0001062993-25-004989 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,038 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:53 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004989 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 7,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003848 · form4.xml · derivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,875 Underlying: Common Stock · 7,875 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003345 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,492 Underlying: Common Stock · 2,247 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 885 | $103.46 | $91,562.10 |
DisclosureSEC source: 0001062993-25-003345 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,768 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003345 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 22:57 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 10,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002911 · form4.xml · derivative · entry 4 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,158 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 22:57 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 2,552 | $101.00 | $257,752.00 |
DisclosureSEC source: 0001062993-25-002911 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,406 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 22:57 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 10,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002911 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 579 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 18, 2025. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 22:57 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 10,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002911 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,158 Underlying: Common Stock · 10,158 shares Expires 2025-02-18 F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · shares: On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 10,518 RSUs, which vested on February 18, 2025. F4 · derivative.underlying_shares: On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 10,518 RSUs, which vested on February 18, 2025. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006023 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 2,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 825 | $125.82 | $103,801.50 |
DisclosureSEC source: 0001062993-24-006023 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,221 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006023 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 1,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005561 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,641 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 646 | $124.28 | $80,284.88 |
DisclosureSEC source: 0001062993-24-005561 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,951 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005561 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 4,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004688 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,580 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 1,769 | $128.80 | $227,847.20 |
DisclosureSEC source: 0001062993-24-004688 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,956 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:57 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004688 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,156 | $0.00 Strike: $91.53 | $0.00 |
DisclosureSEC source: 0001062993-24-004448 · form4.xml · derivative · entry 4 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,156 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 610 | $129.08 | $78,739.23 |
DisclosureSEC source: 0001062993-24-004448 · form4.xml · nonDerivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,145 F3 · price: Reflects the weighted average price of 610 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on February 22, 2024 with sale prices ranging from $129.06 to $129.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 25,546 | $128.61 | $3,285,386.76 |
DisclosureSEC source: 0001062993-24-004448 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,755 F2 · price: Reflects the weighted average price of 25,546 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on February 22, 2024 with sale prices ranging from $128.03 to $128.99 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 26,156 | $91.53 | $2,394,058.68 |
DisclosureSEC source: 0001062993-24-004448 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 474 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 1, 2024. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 02:02 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 6,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004136 · form4.xml · derivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,739 Underlying: Common Stock · 6,739 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,045 | $0.00 Strike: $70.97 | $0.00 |
DisclosureSEC source: 0001062993-23-007358 · form4.xml · derivative · entry 4 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,045 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022. F4 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on March 18, 2014. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 3,302 | $125.09 | $413,043.88 |
DisclosureSEC source: 0001062993-23-007358 · form4.xml · nonDerivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,671 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022. F3 · price: Reflects the weighted average price of 3,302 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2023 with sale prices ranging from $124.87 to $125.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 19,743 | $124.40 | $2,456,068.69 |
DisclosureSEC source: 0001062993-23-007358 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,973 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022. F2 · price: Reflects the weighted average price of 19,743 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2023 with sale prices ranging from $123.85 to $124.84 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 23,045 | $70.97 | $1,635,503.65 |
DisclosureSEC source: 0001062993-23-007358 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:26 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 6,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006282 · form4.xml · derivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,283 Underlying: Common Stock · 6,283 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:53 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004627 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,195 shares Expires 2023-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:53 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 562 | $124.73 | $70,098.26 |
DisclosureSEC source: 0001062993-23-004627 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,671 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:53 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004627 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 158 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through January 27, 2023. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,522 | $0.00 Strike: $70.97 | $0.00 |
DisclosureSEC source: 0001062993-22-023943 · form4.xml · derivative · entry 4 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,045 Underlying: Common Stock · 11,522 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022. F5 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on March 18, 2014. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,063 | $129.34 | $137,492.67 |
DisclosureSEC source: 0001062993-22-023943 · form4.xml · nonDerivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,880 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022. F4 · price: Reflects the weighted average price of 1,063 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on December 13, 2022 with sale prices ranging from $129.02 to $129.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.